McHenry C, Jarosz H, Lawrence A M, Paloyan E
Department of Surgery, Loyola University Medical Center, Maywood, Illinois 60153.
Surg Gynecol Obstet. 1989 Nov;169(5):429-34.
Differentiated carcinoma of the thyroid gland is regarded as an indolent disease. However, this notion is dispelled when the population is stratified according to age, gross and microscopic tumoral characteristics and according to the occurrence of local and distant metastases in the early postoperative period. The adverse effect of local and distant recurrences on survival time has been emphasized in multiple series from the United States and Europe. However, the critical question that has yet to be answered is whether or not inadequately treated differentiated carcinomas of the thyroid gland seemingly cured in younger patients will recur as aggressive, malignant tumors when the same patients reach the graying golden years. A provisional answer to this question may indeed be found in the incidence of early postoperative nodal and distant recurrence rates. Some authors have concluded that the extent of operative treatment does not have a major influence on the course of differentiated carcinoma of the thyroid gland. This conclusion prompted the present follow-up study of 250 patients with differentiated carcinoma of the thyroid gland to examine the clinical course and results of therapy. We report a cumulative mortality rate of 2.4 per cent and a recurrence rate of 1.6 per cent, consisting of a 1.2 per cent incidence of cervical nodal recurrence and a distant recurrence rate of 0.4 per cent (one patient), after a median follow-up period of seven years and a mean of six years. Since there were no differences in treatment and outcome in 191 patients we studied who had papillary and 59 who had follicular carcinoma, they were analyzed as a single group for this report. Total thyroidectomy was the minimal treatment of all operable patients. In addition, 21.0 per cent required a modified dissection of the neck and 8.4 per cent of the patients had postoperative radioactive iodine administered to ablate either remnants of normal tissue or previously undetected metastases to cervical nodes or lungs. Potential factors contributing to improved local and distant recurrence rates included early detection of disease, especially in children who had irradiation and who were recalled and screened (34 per cent in this series); the use of needle aspiration cytologic study, leading to earlier diagnosis and treatment; total thyroidectomy, and the effective use of radioactive iodine administered as a single large dose within the first six months after thyroidectomy.
甲状腺分化型癌被认为是一种进展缓慢的疾病。然而,当根据年龄、肿瘤大体和微观特征以及术后早期局部和远处转移的发生情况对人群进行分层时,这种观念就被打破了。美国和欧洲的多个系列研究都强调了局部和远处复发对生存时间的不利影响。然而,一个尚未得到解答的关键问题是,那些在年轻时看似已治愈的甲状腺分化型癌患者,如果治疗不充分,当他们步入老年时,是否会复发为侵袭性恶性肿瘤。这个问题的一个初步答案或许可以从术后早期淋巴结和远处复发率中找到。一些作者得出结论,手术治疗的范围对甲状腺分化型癌的病程没有重大影响。这一结论促使我们对250例甲状腺分化型癌患者进行了本次随访研究,以考察其临床病程和治疗结果。我们报告,在中位随访期7年、平均随访6年之后,累积死亡率为2.4%,复发率为1.6%,其中颈部淋巴结复发率为1.2%,远处复发率为0.4%(1例患者)。由于我们研究的191例乳头状癌患者和59例滤泡状癌患者在治疗和结果方面没有差异,因此在本报告中将他们作为一个单一组进行分析。全甲状腺切除术是所有可手术患者的最低限度治疗。此外,21.0%的患者需要进行改良颈部清扫术,8.4%的患者术后接受放射性碘治疗,以消除正常组织残余或先前未检测到的颈部淋巴结或肺部转移灶。有助于提高局部和远处复发率的潜在因素包括疾病早期发现,尤其是在接受过放射治疗且被召回并筛查的儿童中(本系列中占34%);使用针吸细胞学检查,从而实现更早的诊断和治疗;全甲状腺切除术,以及在甲状腺切除术后的头6个月内有效使用大剂量单一放射性碘。